THE NEW PROSPECT FOR BODY REGULATION?

Researchers are increasingly investigating retatrutide, a promising medication from Eli Lilly, as a possible breakthrough in body management. Distinct from many existing approaches, retatrutide is a dual -action agonist targeting simultaneously GLP-1 and GIP, hormones that impact satiety and bloo